Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe hypertrophic cardiomyopathy (HCM) caused by pathogenic variants in the RAS/MAPK ...

Researchers from Durham University have made an exciting discovery that could improve how doctors treat dangerous heart ...

Using computers to make a digital replica of the heart – a digital heart twin – can successfully identify problem areas deep ...